Growth factor therapy and autologous lymph node transfer in lymphedema

Trends Cardiovasc Med. 2010 Nov;20(8):249-53. doi: 10.1016/j.tcm.2011.11.008.

Abstract

Lymphedema after cancer treatment is a common clinical challenge, but curative treatment options are rarely available. Lymph node transfer is a novel technique in lymphedema surgery. Lymphatic tissue can be transferred as a vascularized free flap, but in this technique the lymphatic vascular network is expected to regrow spontaneously. Recently, we have learned how to regulate the growth of lymphatic vessels in experimental models. We envision that lymph node transfer should be combined with lymphatic growth factor therapy in the treatment of lymphedema patients.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Combined Modality Therapy
  • Disease Models, Animal
  • Humans
  • Intercellular Signaling Peptides and Proteins / therapeutic use*
  • Lymph Nodes / transplantation*
  • Lymphangiogenesis / drug effects
  • Lymphangiogenesis / physiology
  • Lymphatic System / physiopathology
  • Lymphedema / drug therapy
  • Lymphedema / surgery*
  • Transplantation, Autologous

Substances

  • Intercellular Signaling Peptides and Proteins